Keyphrases
Multiple Sclerosis
100%
Blood Donors
100%
Neurofilament Light (NF-L)
100%
Temporal Dynamics
100%
Light Level
55%
Clinical Onset
22%
Healthy Donors
22%
Axonal Injury
22%
Presymptomatic Phase
22%
Plasma Parameters
11%
Inflammation
11%
Disease Activity
11%
Quality of Life
11%
Progressive multiple Sclerosis
11%
Progressive Disease
11%
Psychological Well-being
11%
Recent Advances
11%
Therapeutic Window
11%
Credible Interval
11%
Plasma Samples
11%
Peripheral Blood
11%
Demyelinating
11%
Demyelination
11%
Primary Progressive
11%
Axonal Damage
11%
Bayesian Approach
11%
Neurodegeneration
11%
Window of Opportunity
11%
First Symptom
11%
CNS Disorders
11%
Intra-individual
11%
Life Data
11%
Advances in Technology
11%
Damage Markers
11%
Model Estimation
11%
Asymptomatic Diseases
11%
Light Dynamics
11%
Immunology and Microbiology
Blood Plasma
100%
Multiple Sclerosis
100%
Dynamics
100%
Neurofilament
100%
Blood Level
11%
Primary Progressive Multiple Sclerosis
11%
Light Chain
11%
Psychological Well-Being
11%
Medicine and Dentistry
Multiple Sclerosis
100%
Neurofilament
100%
Blood Donor
100%
Axonal Injury
22%
Disease Activity
11%
Quality of Life
11%
Progressive Disease
11%
Central Nervous System Disease
11%
Neurodegeneration
11%
Demyelination
11%
Therapeutic Window
11%
Psychological Well-Being
11%
Study Participant
11%
Light Chain
11%
Asymptomatic Disease
11%
Neuroscience
Multiple Sclerosis
100%
Neurofilament
100%
Blood Plasma
100%
Longitudinal Study
12%
Primary Progressive Multiple Sclerosis
12%
Neurodegeneration
12%
Neurofilament Light Chain
12%
Biochemistry, Genetics and Molecular Biology
Dynamics
100%
Blood Plasma
100%
Neurofilament Light
100%
Blood Level
11%
Light Chain
11%
Psychological Well-Being
11%
Pharmacology, Toxicology and Pharmaceutical Science